He did his basic surgical training in West Yorkshire and East Midlands.He got his FRCSEd. in 1993. He became a Research Fellow at the North Western Injury Research Centre, University of Manchester 1993 -1995. His research into “gut permeability after limb ischaemia-reperfusion injury” led to the award of Doctor of Medicine (MD) degree.

His higher surgical training was in hospitals in Newcastle-upon-Tyne and surrounding cities between 1995 and 2001.  He was first appointed a consultant at the City Hospitals Sunderland in 2001.  He moved to Birmingham when he was appointed a consultant at the University Hospital, Birmingham in 2004.  He specialises in bowel cancer, inflammatory bowel disease and benign colorectal disease. He also undertakes common general surgical procedures.

He is a specialist laparoscopic surgeon in both colorectal and general surgery.  He is a skilled and experienced colonoscopist.  He introduced percutaneous endoscopic sigmoidopexy for sigmoid volvulus and chronic pseudoobstruction to the Queen Elizabeth Hospital.

He is course director for the annual national Midlands Ano-Rectal UltraSonography (MARUS) Course since its inception in 2004. 

The Convenor for the Core Surgical Sciences course for the intercollegiate MRCS in Birmingham.

He is faculty member on the annual Intermediate Laparoscopy Course at UHB.

Member of the board of reviewers for the Journal of Surgical Case Reports (JSCR)

He is member of the Association of Coloproctology of Great Britain and Ireland (ACPGBI) and the European Association of Endoscopic Surgeons (EAES).

He is a nationally accreditated screening colonoscopist. His interests include functional bowel problems (including dyspepsia and constipation), inflammatory bowel disease, endoscopy, bowel cancer screening, colonoscopy and polypectomy, and general GI and medical conditions. 

In 2006, he was appointed as a Consultant in Histopathology at Queen Elizabeth Hospital in Birmingham and as an Honorary Senior Lecturer at the University of Birmingham. He is also a member of the Pan Birmingham Cancer Network, Cellular Pathology Group. He has published widely in various peer reviewed clinical and pathology journals.

As part of the national cancer program, all patients with bowel cancer need to be discussed in a multidisciplinary team (MDT) meeting.  As such, since all the specialist in the Gut Clinic, Birmingham have substantive NHS consultants post at the University Hospital Birmingham (UHB), all patients with cancers seen in the private setting are discussed at the UHB MDT meeting.  This allows for a larger group of specialists to deal with each case.

Oncologists within this larger group are used and this could be in the private setting or within the NHS depending on patients’ choice.